Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis.
Mammana S, Bramanti P, Mazzon E, Cavalli E, Basile MS, Fagone P, Petralia MC, McCubrey JA, Nicoletti F, Mangano K.
Mammana S, et al. Among authors: mazzon e.
Oncotarget. 2018 Jan 3;9(9):8263-8277. doi: 10.18632/oncotarget.23862. eCollection 2018 Feb 2.
Oncotarget. 2018.
PMID: 29492193
Free PMC article.